HomeNews

News

News

Monjuvi Combo Reduces Development Danger in Follicular Lymphoma

Editor -
Monjuvi added to Rituxan and Revlimid prolonged progression-free survival from 14 to 22 months in follicular lymphoma: © inventory.adobe.com.Monjuvi, when added to Rituxan...
News

Actual-World Knowledge Helps Amtagvi’s Profit in Superior Melanoma

Editor -
A An actual-world examine confirmed a 49% response charge with Amtagvi in sufferers with superior melanoma: © inventory.adobe.com.Actual-world knowledge from a retrospective examine...
News

The Energy of Suggestion in Breast Most cancers Prevention

Editor -
Promoting is a good advertising and marketing software for a lot of corporations, and we encounter them nearly in all places in our...
News

The Evolution of Survivorship After a Lung Most cancers Analysis

Editor -
Terry Gillespie displays on how her definition of survivorship has developed from her lung most cancers prognosis to current day.For Terry Gillespie, a...
News

Second Opinions Key for These Newly Identified With GIST

Editor -
Dr. Breelyn Wilky of the College of Colorado stated sufferers newly recognized with gastrointestinal stromal tumor (GIST) ought to know they’re not alone.She...
1...267268269...672Page 268 of 672

Hot Topics

Load more

Quick Links

Must Read

Popular Articles

© 2024 Cancer Care Portal. All rights reserved.